|
MXPA05003317A
(es)
|
2002-09-25 |
2005-07-05 |
Memory Pharm Corp |
Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
US20070043079A1
(en)
*
|
2003-04-18 |
2007-02-22 |
Hiromu Habashita |
Heterocyclic compound containing nitrogen atom and use thereof
|
|
PL2256106T3
(pl)
|
2003-07-22 |
2015-08-31 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
|
US8202861B2
(en)
*
|
2003-08-08 |
2012-06-19 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of voltage-gated sodium channels
|
|
WO2005014554A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
DE602004010299T2
(de)
|
2003-12-22 |
2008-09-18 |
Memory Pharmaceuticals Corp. |
Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen
|
|
FR2867778B1
(fr)
*
|
2004-03-16 |
2006-06-09 |
Sanofi Synthelabo |
Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
|
|
NZ550534A
(en)
|
2004-03-25 |
2009-07-31 |
Memory Pharm Corp |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
WO2006001894A1
(en)
|
2004-04-22 |
2006-01-05 |
Memory Pharmaceutical Corporation |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
|
|
JP2007538011A
(ja)
|
2004-05-07 |
2007-12-27 |
メモリー・ファーマシューティカルズ・コーポレイション |
１ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用
|
|
EA012181B1
(ru)
|
2004-10-18 |
2009-08-28 |
Амген, Инк. |
Соединения тиадиазола и их применение
|
|
RU2418797C2
(ru)
|
2004-12-22 |
2011-05-20 |
Мемори Фармасьютиклз Корпорейшн |
Лиганды никотинового рецептора альфа-7, их получение и применение
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
AR052559A1
(es)
*
|
2005-01-21 |
2007-03-21 |
Astex Therapeutics Ltd |
Derivados de pirazol para inhibir cdk's y gsk's
|
|
CA2621983A1
(en)
*
|
2005-09-09 |
2007-03-22 |
Schering Corporation |
Azafused cyclin dependent kinase inhibitors
|
|
JP5255559B2
(ja)
*
|
2006-03-31 |
2013-08-07 |
アボット・ラボラトリーズ |
インダゾール化合物
|
|
WO2007129062A1
(en)
*
|
2006-05-08 |
2007-11-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
|
AU2008276512A1
(en)
|
2007-07-17 |
2009-01-22 |
Amgen Inc. |
Thiadiazole modulators of PKB
|
|
US7897619B2
(en)
|
2007-07-17 |
2011-03-01 |
Amgen Inc. |
Heterocyclic modulators of PKB
|
|
WO2009106980A2
(en)
*
|
2008-02-29 |
2009-09-03 |
Pfizer Inc. |
Indazole derivatives
|
|
JP2013501792A
(ja)
*
|
2009-08-10 |
2013-01-17 |
サミュメッド リミテッド ライアビリティ カンパニー |
Ｗｎｔ／ｂ−カテニンシグナル伝達経路阻害剤としてのインダゾールおよびその治療的使用
|
|
EP2987487B1
(en)
|
2009-08-10 |
2020-10-07 |
Samumed, LLC |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
US20120172369A1
(en)
*
|
2009-09-14 |
2012-07-05 |
Ting Pauline C |
Inhibitors of diacylglycerol acyltransferase
|
|
EP2515655B1
(en)
|
2009-12-21 |
2015-08-05 |
Samumed, LLC |
1h-pyrazolo[3,4-beta]pyridines and therapeutic uses thereof
|
|
CA2799154A1
(en)
|
2010-05-12 |
2011-11-17 |
Abbvie Inc. |
Indazole inhibitors of kinase
|
|
ES2951688T3
(es)
|
2011-02-28 |
2023-10-24 |
Epizyme Inc |
Compuestos de heteroarilo biciclico fusionados en 6,5 sustituidos
|
|
EP3473099A1
(en)
*
|
2011-09-14 |
2019-04-24 |
Samumed, LLC |
Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
|
CA2860672A1
(en)
|
2012-01-06 |
2013-07-11 |
University Of South Florida |
Compositions, methods of use, and methods of treatment
|
|
RS54539B1
(sr)
|
2012-02-21 |
2016-06-30 |
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. |
Upotreba 1h-indazol-3-karboksamidnih jedinjenja kao inhibitora kinaze 3-beta glikogen sintetaze
|
|
CA2860250C
(en)
*
|
2012-02-21 |
2020-11-10 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
EP2770994B1
(en)
|
2012-05-04 |
2019-08-21 |
Samumed, LLC |
1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
EP2935248B1
(en)
*
|
2012-12-21 |
2018-02-28 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2014110086A2
(en)
*
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
|
MX2016012208A
(es)
|
2014-03-20 |
2017-01-26 |
Samumed Llc |
Indazol-3-carboxamidas 5-substituidas y preparacion y uso de las mismas.
|
|
WO2015200650A1
(en)
*
|
2014-06-25 |
2015-12-30 |
Epizyme, Inc. |
Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
BR112018009252A2
(pt)
|
2015-11-06 |
2018-11-06 |
Samumed Llc |
tratamento da osteoartrite
|
|
EA201891170A1
(ru)
|
2015-11-18 |
2018-11-30 |
Джензим Корпорейшн |
Биомаркер поликистозной болезни почек и варианты его применения
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
LT3464285T
(lt)
|
2016-06-01 |
2022-12-27 |
Biosplice Therapeutics, Inc. |
N-(5-(3-(7-(3-fluorfenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)- 3-metilbutanamido gamybos būdas
|
|
CN110709082A
(zh)
|
2016-10-21 |
2020-01-17 |
萨穆梅德有限公司 |
吲唑-3-甲酰胺的使用方法及其作为Wnt/β-连环蛋白信号传导途径抑制剂的用途
|
|
US10758523B2
(en)
|
2016-11-07 |
2020-09-01 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
|
US10807966B2
(en)
|
2016-11-21 |
2020-10-20 |
Translational Drug Development, Llc |
Heterocyclic compounds as kinase inhibitors
|
|
CN110506038B
(zh)
*
|
2017-03-28 |
2023-11-24 |
巴斯夫欧洲公司 |
杀害虫化合物
|
|
AU2019224075A1
(en)
|
2018-02-23 |
2020-09-10 |
Samumed, Llc |
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
|
|
PT3790873T
(pt)
|
2018-05-07 |
2022-05-11 |
Acraf |
Compostos de 1h-indazole-3-carboxamida como inibidores da glicogénio sintase cinase 3 beta
|
|
CN115605460A
(zh)
|
2020-04-29 |
2023-01-13 |
普莱希科公司（Us） |
杂环化合物的合成
|
|
CN112778203B
(zh)
*
|
2021-01-29 |
2022-02-15 |
兰州交通大学 |
1h-吲唑-3-羧酸衍生物及格拉斯琼和氯尼达明的制备方法
|
|
CN114605329B
(zh)
*
|
2022-03-28 |
2024-01-26 |
河南中医药大学 |
取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
|
|
JP2025530213A
(ja)
|
2022-09-09 |
2025-09-11 |
ミリックス ファーマ リミテッド |
Ｎｍｔ阻害剤を含む抗体薬物コンジュゲート及びその使用
|
|
WO2024109642A1
(zh)
*
|
2023-07-28 |
2024-05-30 |
常州大学 |
一种苯并氮杂环类化合物作为β2-肾上腺素受体别构调节剂的应用
|
|
WO2026024674A1
(en)
|
2024-07-22 |
2026-01-29 |
Genesis Therapeutics, Inc. |
Methods of treating skp2-associated cancers
|